Global Rare Sugar Market - 2023-2030

Market Overview

The global rare sugar market reached US$ XX million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of 4.2% during the forecast period (2023-2030).

Monosaccharides and their derivatives, which are present in nature in incredibly small amounts, are rare sugars. There are over 50 different types of simple sugars, but only seven are found in significant quantities. These sugars are L-arabinose, D-ribose, D-xylose, D-fructose, D-mannose, D-galactose and D-glucose. The remaining sugar is rare and has a sweetness level of 70% of regular sugar.

The building blocks to synthesize nucleoside analogs, which are used as antiviral and anti-cancer agents, use rare sugars. They are prepared to create the same compound using organic processes like fermentation or enzyme conversion.

Despite their low natural abundance, rare sugars have many important applications, including their use as components in antiviral medications. Furthermore, because of their low glycemic index, they are used as low-calorie sweeteners. They also serve as anti-inflammatory drugs because of their immunosuppressive qualities.

Market Dynamics

Increase in health consciousness among consumers

The consumption of rare sugar helps in providing benefits for health-conscious consumers. For instance, D-Mannose monosaccharide significantly blunts insulin response and reduces the impact on blood sugar level, thus making it a better alternative as natural sugar in different functional food and beverages. It is also not stored in the liver like glucose and is absorbed more slowly in the gastrointestinal tract, thus accounting for a lower glycemic index, propelling the growth of the rare sugar market. It is anticipated that national government initiatives in France and the U.K. to reduce sugar consumption through selective taxation, product reformulations and explanatory front packaging labels will aid market expansion. These initiatives support WHO's 2015-2020 European Food and Nutrition Action Plan's policy recommendations for fostering a healthier food environment.

Adherence to international quality standards and regulations

It is anticipated that a significant restraint on the growth of the rare sugar market will come from stringent regulations and compliances designed to safeguard consumers' interests through strict labeling and manufacturing practices.

For instance, in April 2019, the U.S. Food and Drug Administration established guidelines on the number of calories in allulose for nutrition and supplementation. To qualify as low-sugar or low-calorie products under this legislation, manufacturers of rare sugar must adhere to stringent regulations. The rare sugar market is anticipated to face challenges due to such factors.

COVID-19 Impact Analysis

The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with pricing dynamics (including pricing change during and post-pandemic comparing it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), government initiatives (initiatives to revive market, sector or industry by government bodies) and manufacturers strategic initiatives (what manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global rare sugar market is segmented based on product, end-user and region.

Rising prevalence of urinary tract infections globally

D-Mannose segment in the rare sugar market is expected to hold a significant global market share. D-mannose is often sold as a dietary supplement for lowering the incidence of UTIs. According to research, augmented D-mannose may be a potential alternative or supplemental therapy, particularly as a preventive for recurrent UTIs. D-mannose, when discharged in urine, may prevent Escherichia coli, the principal causative bacterium of UTIs, from adhering to urothelium and causing infection. D-mannose may also prevent some types of bacteria from adhering to the urinary system walls and causing illness.

D-mannose may be safe for most individuals for up to 6 months when taken orally. Nonetheless, it has the potential to cause diarrhea and nausea.

Due to the growing demand for D-mannose treating UTIs, many manufacturers are launching new probiotic products with the respective compound. For instance, Labiana pharmaceuticals launched Precyst, a new food supplement to help the well-being of the urinary system in women, on December 16, 2020. The product comprises two natural substances with synergistic effects: D-Mannose and cranberry extract.

Furthermore, Utiva launched a new line of urinary tract health and wellness products on March 11, 2021. The new product line comprises point-of-need solutions named Utiva UTI Control 36PAC Cranberry Pills, Probiotic Power Supplements and D-Mannose Attack, some effective wellness triumvirates capable of preventing urinary tract infections.

Geographical Analysis

Asia-Pacific's growing demand for organic food and increased knowledge of healthy lifestyles and diets

According to the International Trade Centre, Japan imported the most chemically pure sugars in 2021, totaling 62,314 tons. China also imported 10,120 tons of chemically pure sugar.

Global firms are developing and entering this market area in this region through collaboration and partnership with others to expand their regional growth. For instance, GNC Holdings Inc engaged in a relationship with a Hong Kong-based Chinese e-Commerce firm in February 2019 to expand the product range of supplements such as Now D-Mannose and Source Naturals D-Mannose in China's supplement industry.

EIAs for Anhui Tiankai's nutritional supplements healthy industry project and functional and nutritional healthy food project were made public on May 17, 2021, before approval by the Government of Quanjiao County. Both projects will include allulose production lines with a total capacity of 2,500 t/a.

Baolingbao Biology Co., Ltd. stated in a Q&A forum for investors in November 2021 that the business has made full preparations for future domestic licensing of the usage of psicose.

Earlier on August 25, BLB announced the launch of a 30,000 t/a psicose (dry basis) project to prepare for the anticipated psicose market in China and meet demand from abroad markets. The project has a total investment of US$ 58.82 million (RMB380 million) and a construction span of two years; it is now in the planning stages. These development operations will generate new opportunities for regional market expansion.

Competitive Landscape

The major global players in the market include Ingredion Incorporated, Nestle, Avantor, Inc, Tate & Lyle, Jarrow Formulas Inc, Shijiazhuang Huaxu Pharmaceutical Co.,Ltd, Sanwa Starch Co., Ltd., Zhangjiagang Sipu Biochemical Co., Ltd, Sweet Cures Limited, and Matsutani Chemical Industry Co. Ltd.

Why Purchase the Report?

• To visualize the global rare sugar market segmentation based on product, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of rare sugar market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global rare sugar market report would provide approximately 53 tables, 51 figures and 202 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies